Vitamin D Pilot Study in Patients With Multiple Sclerosis
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Phase 1 study of 19-nor Vitamin D in relapsing-remitting MS. Primary measure is MRI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Feb 1998
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 1998
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2000
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2000
CompletedFirst Submitted
Initial submission to the registry
December 8, 2010
CompletedFirst Posted
Study publicly available on registry
December 10, 2010
CompletedOctober 5, 2015
December 1, 2010
2 years
December 8, 2010
October 1, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
MRI Measure of new active lesions, observation vs. treatment
Study Arms (1)
19 nor vitamin d
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- relapsing remitting MS
You may not qualify if:
- MRI contraindicated
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UW-Madison
Madison, Wisconsin, 53792, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 8, 2010
First Posted
December 10, 2010
Study Start
February 1, 1998
Primary Completion
February 1, 2000
Study Completion
June 1, 2000
Last Updated
October 5, 2015
Record last verified: 2010-12